Showing results (1651-1660 of 2,224) with videos related to
Sort By:
Pageof 223
Acta Neuropathologica Communications|February 2, 2017
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's diseaseChi Wang Ip, Laura-Christin Klaus, Akua A Karikari, et al.Social Science & Medicine (1982)|January 17, 2017
Effects of assisted outpatient treatment and health care services on psychotic symptomsAndres R Schneeberger, Christian G Huber, Undine E Lang, et al.Annals of Neurology|August 5, 2004
Bilateral globus pallidus stimulation for Huntington's diseaseElena Moro, Anthony E Lang, Antonio P Strafella, et al.International Journal of Environmental Research and Public Health|January 24, 2019
Differences in Insomnia Symptoms between Immigrants and Non-Immigrants in Switzerland attributed to Emotional Distress: Analysis of the Swiss Health SurveyAndres R Schneeberger, Azizi Seixas, Nina Schweinfurth, et al.Frontiers in Pediatrics|March 18, 2024
Referent data for investigations of upper limb accelerometry: harmonized data from three cohorts of typically-developing childrenCatherine E Lang, Catherine R Hoyt, Jeffrey D Konrad, et al.The Lancet. Neurology|January 24, 2024
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteriaGünter U Höglinger, Charles H Adler, Daniela Berg, et al.Annals of Neurology|December 3, 2014
Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson diseaseLeigh Christopher, Sarah Duff-Canning, Yuko Koshimori, et al.Journal of Neuroengineering and Rehabilitation|May 1, 2016
Computational neurorehabilitation: modeling plasticity and learning to predict recoveryDavid J Reinkensmeyer, Etienne Burdet, Maura Casadio, et al.Journal of Neurology|October 20, 1999
Posteroventral medial pallidotomy in Parkinson's diseaseA E Lang, J Duff, J A Saint-Cyr, et al.Cancer Research|November 1, 1981
Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group ProjectR T Chlebowski, J M Weiner, J Luce, et al.Pageof 223